No, we know they need more to get to commercialization without a doubt. The question now is, "how do they get it?"
I am a pretty optimistic guy, but this is troublesome.
The shelf is still looming and IF the interest is not enough after SAGES and AORN to get warrants going then they will have to go right back to it meaning we go through this whole damned process again.
Market Data 
Markets 
AI
